查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1179503

3D 細胞培養市場：按產品、應用、最終用戶分類：2021-2031 年全球機遇分析和行業預測

3D Cell Culture Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 244 Pages | 商品交期: 2-3個工作天內

價格

3D 細胞培養是一種體外技術，可讓細胞在人工創造的環境中生長。

這些環境與本地組織的結構和功能非常相似。 3D 細胞培養技術通過與類似於體內的三維環境相互作用，幫助刺激細胞分化、增殖和遷移。 由於 3D 細胞培養可以模擬體內組織的結構、活動和微環境，因此該技術在藥物篩選、再生醫學、幹細胞治療、癌症研究和細胞生物學方面具有許多潛在應用。 在 3D 培養中，細胞外基質分泌細胞因子和營養因子，並進行直接接觸以實現細胞間通訊，類似於體內環境。 二維環境中這些因素的變化會深刻影響細胞間的通訊，導致細胞形態和增殖發生改變。 這種技術在醫療保健研究領域越來越受歡迎，因為 2D 培養物無法再現 3D 培養物的結構和復雜細胞基質。 此外，3D 細胞培養可以提高效率並降低整個研發過程的成本。

3D 細胞培養市場按產品細分為基於支架的平台、無支架平台、凝膠、生物反應器、微芯片和服務。 基於支架的平台用於通過提供一個表面來修改細胞培養程序，細胞可以在該表面上輕鬆地進行 3D 生長。 支架用於藥物發現和細胞生長，因為它們有多種材料和結構可供選擇。 支架也很容易成像，並具有簡單化驗協議的優勢。 此外，支架的機械和生化特性可以根據應用需要輕鬆修改。 因此，由於對用於創建 3D 細胞培養的基於腳手架的平台的高需求，預計該細分市場將在整個預測期內主導產品細分市場。 然而，基於支架的平台可以通過吸附測試物質、限制下游端點進行分析以及允許引入不同的生物物質來抑製片段生長。

根據應用，3D 細胞培養市場分為癌症研究、幹細胞研究、藥物發現和再生醫學。 癌症研究領域預計將成為分析期內增長最大的領域。 這包括促進細胞生長和改變形態，揭示真實的藥物反應，捕捉表型異質性，以及實現基因表達和細胞行為的實驗操作。，以代表腫瘤微環境。 利用 3D 細胞培養優勢的早期臨床前研究可以決定性地提高我們對癌症生物學的理解。 這包括消除較差的候選藥物和識別以前在二維培養中無法獲得的生理學相關目標。 這可能會顯著促進該細分市場的增長。

根據最終用戶，全球 3D 細胞培養市場分為生物技術和製藥公司、合同研究機構和學術機構。 在整個分析期間，學術機構部門在最終用戶領域佔據主導地位。 由於各種醫療保健應用對 3D 細胞培養的需求不斷增加，這種增長歸因於研究機構和臨床實驗室以及多家公司之間的合作增加。 例如，Procter &Gamble (P&G) 和英國杜倫大學正在合作創建 3D 皮膚替代品，使用模擬組織的 2D 平台來研究體外衰老過程。 此外，許多學術機構將研發活動的重點放在 3D 培養模型上，以開發治療各種疾病的新方法。 學術機構和大學研究活動的激增預計將在分析期間推動該領域的增長。

在預測期內，北美將繼續佔據主導地位，因為有幾家製藥和生物技術公司與研究機構和臨床實驗室合作使用 3D 培養技術進行再生醫學和藥物發現開發。預計將保持這一趨勢。 此外，器官移植需求的增加以及專注於技術先進解決方案的研發活動的增加預計將推動該地區採用 3D 細胞培養。 此外，癌症發病率的激增導致政府增加了對癌症□□領域研發的資金和補貼，這可能對 3D 細胞培養市場的增長產生積極影響。 此外，生物技術和製藥公司的戰略擴張推出了先進的產品，預計將在未來幾年推動市場增長。

對利益相關者的主要好處

本報告定量分析了 2021 年至 2031 年 3D 細胞培養市場分析的細分市場、當前趨勢、估計和動態，以確定 3D 細胞培養市場的主要機會。

市場研究提供了有關關鍵驅動因素、市場限制和機會的信息。

波特的五力分析強調了買家和供應商在幫助利益相關者做出以利潤為導向的商業決策和加強供應商-買家網絡方面的潛力。

對 3D 細胞培養市場細分的詳細分析有助於確定總體市場機會。

每個地區的主要國家根據其對全球市場的收入貢獻進行映射。

市場參與者定位有助於進行基準測試，並提供對市場參與者當前位置的清晰了解。

本報告分析了區域和全球 3D 細胞培養市場趨勢、主要參與者、細分市場、應用領域和市場增長戰略。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析

第 4 章 3D 細胞培養市場：按產品分類

  • 概覽
    • 市場規模和預測
  • 基於腳手架的平台
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：國家分析
    • 支架平台 3D 細胞培養市場：按宏觀分類
    • 支架平台 3D 細胞培養市場：按微型分類
    • 支架平台 3D 細胞培養市場：按納米級分類
    • 基於支架的 3D 細胞培養平台市場：按固體支架分類
  • 無腳手架平台
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：國家分析
  • 凝膠
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 生物反應器
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 微芯片
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 服務
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 5 章 3D 細胞培養市場：按應用

  • 概覽
    • 市場規模和預測
  • 癌症研究
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 幹細胞研究
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 藥物發現
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 再生醫學
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 6 章 3D 細胞培養市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 生物技術公司、製藥公司
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 調查機構
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 學術機構
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 7 章 3D 細胞培養市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模和預測：按產品
    • 北美市場規模和預測：按應用
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲市場規模和預測：按產品
    • 歐洲市場規模和預測：按應用分類
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 其他歐洲地區
  • 亞太地區
    • 主要趨勢和機會
    • 亞太市場規模和預測：按產品
    • 亞太市場規模和預測：按應用
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 日本
      • 中國
      • 印度
      • 澳大利亞
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機會
    • LAMEA 市場規模和預測：按產品
    • LAMEA 市場規模和預測：按應用分類
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其餘部分

第八章公司情況

  • 簡介
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第九章公司簡介

  • 3d Biotek LLC
  • Advanced Biomatrix, Inc.
  • Avantor, Inc.
  • Becton, Dickinson And Company
  • Corning Incorporated
  • Insphero AG
  • Lonza Group LTD.
  • Merck & Co., Inc.
  • Synthecon, Incorporated
  • Thermo Fisher Scientific Inc.
Product Code: A01155

A 3D cell culture is an in-vitro technique wherein the cells can grow in an artificially created environment. These environments closely resemble the architecture and functioning of the native tissue. 3D cell culture technique helps stimulate cell differentiation, proliferation, and migration by interacting with their three-dimensional surroundings as they would in the in-vivo environment. As 3D cell cultures can mimic the structure, activity, and microenvironment of the in-vivo tissues, this technique has varied applications in the fields of drug screening, regenerative medicine, stem cell therapies, cancer research and cell biology. The extracellular matrix in 3D cell cultures enables cell-cell communication by direct contact as in in-vivo environment by secreting cytokines and trophic factors. These factors are changed in a 2D environment that can significantly affect the cell-cell communication, which in turn can alter the cell morphology and proliferation. As 2D cultures cannot recapitulate the architecture and complex cellular matrices as in 3D cultures, this technique is gaining popularity in healthcare research sector. In addition, 3D cell cultures can provide results with improved efficiency and reduce the cost of overall R&D process. 

Based on product, the 3D cell culture market can be categorized into scaffold-based platforms, scaffold-free platforms, gels, bioreactors, microchips, and services. Scaffold-based platforms are used to alter the cell culture procedure by providing a surface on which the cells can easily impart 3D growth. Scaffolds are used in drug discovery and cell expansion, owing to the availability of a variety of materials and structural choices. In addition, there are other advantages related to the use of scaffold-based platforms such as ease of imaging and simple assay protocol. Moreover, the mechanical and biochemical properties of the scaffold can easily be modified as per the need of the application. Thus, this segment is expected to dominate the product segment throughout the forecast period as there is a high demand for scaffold-based platforms for creating 3D cell cultures. Nevertheless, scaffold-based platforms can adsorb test compounds, limit downstream endpoints for analysis, and introduce different biological substances, thereby obstructing the segment growth.

Based on application, the 3D cell culture market is segmented into cancer research, stem cell research, drug discovery, and regenerative medicine. Cancer research segment is anticipated to be the largest growing segment over the analysis period. This is majorly attributed to the advantages offered by 3D cell culture in cancer research, these include ease of altering cell proliferation and morphology, revealing realistic drug response, capturing phenotypic heterogeneity, allowing experimental manipulation in gene expression & cell behavior and representing the tumor microenvironment. Preclinical studies that utilize the benefits of 3D cell culture early on can critically improvise the understanding of cancer biology. These include elimination of poor drug candidates and identification of physiologically relevant targets that were previously inaccessible in 2D cultures. This can largely contribute toward the segment growth.

Based on end user, the global 3D cell culture market is segmented into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. The academic institutes segment held a dominant position in the end user segment throughout the analysis period. This growth is due to rise in collaborations between several companies with research institutes and clinical laboratories owing to the rise in demand of 3D cell cultures for various healthcare applications. For instance, Procter & Gamble (P&G) and Durham University based in the UK have collaborated for engineering 3D skin substitutes with the help of tissue-mimetic 2D platforms for studying the process of ageing in-vitro. In addition, many academic institutes have focused their R&D activities toward 3D culture models for developing novel approaches for treating different medical conditions. This surge in research activities across academic institutes and universities is predicted to propel the growth of the segment over the analysis period.

North America is expected to maintain its dominance during the forecast period due to the presence of several pharmaceutical and biotechnology companies that use 3D culture technology in collaboration with research institutes and clinical laboratories for developing regenerative medicines and drug discovery & development. Furthermore, rise in demand for organ transplantation and upsurge in R&D activities focused on technologically advanced solutions is predicted to fuel the adoption of 3D cell culture practices in the region. In addition, surge in incidences of cancer has led the government to increase the funding and grants for R&D in the field of cancer, which may have a positive impact on the 3D cell culture market growth. Moreover, the strategic expansion of biotechnological and pharmaceutical companies has led to launch of advanced products, which are expected to augment the market growth in coming years.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the 3d cell culture market analysis from 2021 to 2031 to identify the prevailing 3d cell culture market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the 3d cell culture market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global 3d cell culture market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Scaffold Free Platforms
  • Gels
  • Bioreactors
  • Microchips
  • Services
  • Scaffold Based Platforms
    • Macro-scale
    • Micro-scale
    • Nano-scale
    • Solid Scaffolds

By Application

  • Cancer Research
  • Stem Cell Research
  • Drug Discovery
  • Regenerative medicine

By End User

  • Biotechnology and Pharmaceutical Companies
  • Contract Research Laboratories
  • Academic Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Rest of Asia-Pacific
    • Japan
    • China
    • India
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • 3d Biotek LLC
    • Advanced Biomatrix, Inc.
    • Avantor, Inc.
    • Becton, Dickinson And Company
    • Corning Incorporated
    • Insphero AG
    • Lonza Group LTD.
    • Merck & Co., Inc.
    • Synthecon, Incorporated
    • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: 3D CELL CULTURE MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Scaffold Based Platforms
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Scaffold Based Platforms 3D Cell Culture Market by Macro-scale
    • 4.2.5 Scaffold Based Platforms 3D Cell Culture Market by Micro-scale
    • 4.2.6 Scaffold Based Platforms 3D Cell Culture Market by Nano-scale
    • 4.2.7 Scaffold Based Platforms 3D Cell Culture Market by Solid Scaffolds
  • 4.3 Scaffold Free Platforms
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Gels
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Bioreactors
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
  • 4.6 Microchips
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country
  • 4.7 Services
    • 4.7.1 Key market trends, growth factors and opportunities
    • 4.7.2 Market size and forecast, by region
    • 4.7.3 Market analysis by country

CHAPTER 5: 3D CELL CULTURE MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Cancer Research
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Stem Cell Research
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Drug Discovery
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Regenerative medicine
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: 3D CELL CULTURE MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Biotechnology and Pharmaceutical Companies
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Contract Research Laboratories
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Academic Institutes
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: 3D CELL CULTURE MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Product
      • 7.2.5.1.2 Market size and forecast, by Application
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Product
      • 7.2.5.2.2 Market size and forecast, by Application
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Product
      • 7.2.5.3.2 Market size and forecast, by Application
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Product
      • 7.3.5.1.2 Market size and forecast, by Application
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Product
      • 7.3.5.2.2 Market size and forecast, by Application
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Product
      • 7.3.5.3.2 Market size and forecast, by Application
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Rest of Europe
      • 7.3.5.4.1 Market size and forecast, by Product
      • 7.3.5.4.2 Market size and forecast, by Application
      • 7.3.5.4.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Product
      • 7.4.5.1.2 Market size and forecast, by Application
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Product
      • 7.4.5.2.2 Market size and forecast, by Application
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Product
      • 7.4.5.3.2 Market size and forecast, by Application
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Product
      • 7.4.5.4.2 Market size and forecast, by Application
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Market size and forecast, by Product
      • 7.4.5.5.2 Market size and forecast, by Application
      • 7.4.5.5.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Product
      • 7.5.5.1.2 Market size and forecast, by Application
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Product
      • 7.5.5.2.2 Market size and forecast, by Application
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Product
      • 7.5.5.3.2 Market size and forecast, by Application
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Product
      • 7.5.5.4.2 Market size and forecast, by Application
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 3d Biotek LLC
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Advanced Biomatrix, Inc.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Avantor, Inc.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Becton, Dickinson And Company
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Corning Incorporated
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Insphero AG
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Lonza Group LTD.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Merck & Co., Inc.
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Synthecon, Incorporated
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Thermo Fisher Scientific Inc.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 2. 3D CELL CULTURE MARKET SIZE, FOR SCAFFOLD BASED PLATFORMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. 3D CELL CULTURE MARKET FOR SCAFFOLD BASED PLATFORMS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY MACRO-SCALE, 2021-2031 ($MILLION)
  • TABLE 5. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY MICRO-SCALE, 2021-2031 ($MILLION)
  • TABLE 6. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY NANO-SCALE, 2021-2031 ($MILLION)
  • TABLE 7. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY SOLID SCAFFOLDS, 2021-2031 ($MILLION)
  • TABLE 8. 3D CELL CULTURE MARKET SIZE, FOR SCAFFOLD FREE PLATFORMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. 3D CELL CULTURE MARKET FOR SCAFFOLD FREE PLATFORMS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. 3D CELL CULTURE MARKET SIZE, FOR GELS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. 3D CELL CULTURE MARKET FOR GELS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 12. 3D CELL CULTURE MARKET SIZE, FOR BIOREACTORS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. 3D CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. 3D CELL CULTURE MARKET SIZE, FOR MICROCHIPS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. 3D CELL CULTURE MARKET FOR MICROCHIPS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. 3D CELL CULTURE MARKET SIZE, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. 3D CELL CULTURE MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 18. GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 19. 3D CELL CULTURE MARKET SIZE, FOR CANCER RESEARCH, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. 3D CELL CULTURE MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. 3D CELL CULTURE MARKET SIZE, FOR STEM CELL RESEARCH, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. 3D CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. 3D CELL CULTURE MARKET SIZE, FOR DRUG DISCOVERY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. 3D CELL CULTURE MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. 3D CELL CULTURE MARKET SIZE, FOR REGENERATIVE MEDICINE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. 3D CELL CULTURE MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. GLOBAL 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 28. 3D CELL CULTURE MARKET SIZE, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 29. 3D CELL CULTURE MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 30. 3D CELL CULTURE MARKET SIZE, FOR CONTRACT RESEARCH LABORATORIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 31. 3D CELL CULTURE MARKET FOR CONTRACT RESEARCH LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. 3D CELL CULTURE MARKET SIZE, FOR ACADEMIC INSTITUTES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 33. 3D CELL CULTURE MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 34. 3D CELL CULTURE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 35. NORTH AMERICA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 36. NORTH AMERICA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 37. NORTH AMERICA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. NORTH AMERICA 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 39. U.S. 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 40. U.S. 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 41. U.S. 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. CANADA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 43. CANADA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 44. CANADA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 45. MEXICO 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 46. MEXICO 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. MEXICO 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 49. EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 50. EUROPE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 51. EUROPE 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 52. GERMANY 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 53. GERMANY 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 54. GERMANY 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. FRANCE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 56. FRANCE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 57. FRANCE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. UK 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 59. UK 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 60. UK 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 68. JAPAN 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 71. CHINA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 72. CHINA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 73. CHINA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 74. INDIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 75. INDIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. INDIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. AUSTRALIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 80. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 81. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 82. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 83. LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 84. LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 85. LAMEA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 86. LAMEA 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 87. BRAZIL 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 88. BRAZIL 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 89. BRAZIL 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 90. SAUDI ARABIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 91. SAUDI ARABIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 92. SAUDI ARABIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. SOUTH AFRICA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 94. SOUTH AFRICA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 95. SOUTH AFRICA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 96. REST OF LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 97. REST OF LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 98. REST OF LAMEA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 99.3D BIOTEK LLC: COMPANY SNAPSHOT
  • TABLE 100.3D BIOTEK LLC: OPERATING SEGMENTS
  • TABLE 101.3D BIOTEK LLC: PRODUCT PORTFOLIO
  • TABLE 102.3D BIOTEK LLC: NET SALES,
  • TABLE 103.3D BIOTEK LLC: KEY STRATERGIES
  • TABLE 104.ADVANCED BIOMATRIX, INC.: COMPANY SNAPSHOT
  • TABLE 105.ADVANCED BIOMATRIX, INC.: OPERATING SEGMENTS
  • TABLE 106.ADVANCED BIOMATRIX, INC.: PRODUCT PORTFOLIO
  • TABLE 107.ADVANCED BIOMATRIX, INC.: NET SALES,
  • TABLE 108.ADVANCED BIOMATRIX, INC.: KEY STRATERGIES
  • TABLE 109.AVANTOR, INC.: COMPANY SNAPSHOT
  • TABLE 110.AVANTOR, INC.: OPERATING SEGMENTS
  • TABLE 111.AVANTOR, INC.: PRODUCT PORTFOLIO
  • TABLE 112.AVANTOR, INC.: NET SALES,
  • TABLE 113.AVANTOR, INC.: KEY STRATERGIES
  • TABLE 114.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 115.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 116.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 117.BECTON, DICKINSON AND COMPANY: NET SALES,
  • TABLE 118.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
  • TABLE 119.CORNING INCORPORATED: COMPANY SNAPSHOT
  • TABLE 120.CORNING INCORPORATED: OPERATING SEGMENTS
  • TABLE 121.CORNING INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 122.CORNING INCORPORATED: NET SALES,
  • TABLE 123.CORNING INCORPORATED: KEY STRATERGIES
  • TABLE 124.INSPHERO AG: COMPANY SNAPSHOT
  • TABLE 125.INSPHERO AG: OPERATING SEGMENTS
  • TABLE 126.INSPHERO AG: PRODUCT PORTFOLIO
  • TABLE 127.INSPHERO AG: NET SALES,
  • TABLE 128.INSPHERO AG: KEY STRATERGIES
  • TABLE 129.LONZA GROUP LTD.: COMPANY SNAPSHOT
  • TABLE 130.LONZA GROUP LTD.: OPERATING SEGMENTS
  • TABLE 131.LONZA GROUP LTD.: PRODUCT PORTFOLIO
  • TABLE 132.LONZA GROUP LTD.: NET SALES,
  • TABLE 133.LONZA GROUP LTD.: KEY STRATERGIES
  • TABLE 134.MERCK & CO., INC.: COMPANY SNAPSHOT
  • TABLE 135.MERCK & CO., INC.: OPERATING SEGMENTS
  • TABLE 136.MERCK & CO., INC.: PRODUCT PORTFOLIO
  • TABLE 137.MERCK & CO., INC.: NET SALES,
  • TABLE 138.MERCK & CO., INC.: KEY STRATERGIES
  • TABLE 139.SYNTHECON, INCORPORATED: COMPANY SNAPSHOT
  • TABLE 140.SYNTHECON, INCORPORATED: OPERATING SEGMENTS
  • TABLE 141.SYNTHECON, INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 142.SYNTHECON, INCORPORATED: NET SALES,
  • TABLE 143.SYNTHECON, INCORPORATED: KEY STRATERGIES
  • TABLE 144.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 145.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 146.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 147.THERMO FISHER SCIENTIFIC INC.: NET SALES,
  • TABLE 148.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.3D CELL CULTURE MARKET SEGMENTATION
  • FIGURE 2.3D CELL CULTURE MARKET,2021-2031
  • FIGURE 3.3D CELL CULTURE MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.3D CELL CULTURE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.3D CELL CULTURE MARKET,BY PRODUCT,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SCAFFOLD FREE PLATFORMS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF GELS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BIOREACTORS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MICROCHIPS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SERVICES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 19.3D CELL CULTURE MARKET,BY APPLICATION,2021(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CANCER RESEARCH 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF STEM CELL RESEARCH 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF REGENERATIVE MEDICINE 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 24.3D CELL CULTURE MARKET,BY END USER,2021(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF CONTRACT RESEARCH LABORATORIES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF ACADEMIC INSTITUTES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 28.3D CELL CULTURE MARKET BY REGION,2021
  • FIGURE 29.U.S. 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 30.CANADA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 31.MEXICO 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 32.GERMANY 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 33.FRANCE 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 34.UK 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF EUROPE 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 36.JAPAN 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 37.CHINA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 38.INDIA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 39.AUSTRALIA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 41.BRAZIL 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 42.SAUDI ARABIA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 43.SOUTH AFRICA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 44.REST OF LAMEA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49.COMPETITIVE DASHBOARD
  • FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 51.3D BIOTEK LLC.: NET SALES ,($MILLION)
  • FIGURE 52.ADVANCED BIOMATRIX, INC..: NET SALES ,($MILLION)
  • FIGURE 53.AVANTOR, INC..: NET SALES ,($MILLION)
  • FIGURE 54.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
  • FIGURE 55.CORNING INCORPORATED.: NET SALES ,($MILLION)
  • FIGURE 56.INSPHERO AG.: NET SALES ,($MILLION)
  • FIGURE 57.LONZA GROUP LTD..: NET SALES ,($MILLION)
  • FIGURE 58.MERCK & CO., INC..: NET SALES ,($MILLION)
  • FIGURE 59.SYNTHECON, INCORPORATED.: NET SALES ,($MILLION)
  • FIGURE 60.THERMO FISHER SCIENTIFIC INC..: NET SALES ,($MILLION)